Clear Harbor Asset Management LLC acquired a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 42,883 shares of the company’s stock, valued at approximately $5,511,000.
A number of other large investors have also recently bought and sold shares of the stock. Keating Financial Advisory Services Inc. bought a new stake in shares of Merck KGaA in the 2nd quarter worth about $592,000. Tocqueville Asset Management L.P. bought a new position in Merck KGaA during the 2nd quarter valued at about $57,546,000. August Group Capital Ltd bought a new position in Merck KGaA during the 2nd quarter valued at about $390,000. Great Lakes Advisors LLC acquired a new position in Merck KGaA in the second quarter valued at about $183,444,000. Finally, Bell & Brown Wealth Advisors LLC acquired a new position in Merck KGaA in the second quarter valued at about $5,662,000. 0.10% of the stock is currently owned by institutional investors.
Merck KGaA Stock Performance
OTCMKTS MKGAF opened at $163.21 on Friday. The firm has a market cap of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96. The company has a 50 day moving average of $162.62 and a 200-day moving average of $148.46. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
